Track the 엑셀세라퓨틱스 share price and the full management transaction log of the company, a publicly traded company based in South Korea. Shares are quoted on the KR market, under the supervision of DART (FSS). Operating in the Health Care sector, 엑셀세라퓨틱스 has logged 18 reports. Market capitalisation: €18.7bn. The latest transaction was filed on 1 April 2026 (Purchase). Among the most active insiders: 이의일. The full history is openly available.
18
Insider Decl.
n/a
Thresholds
€17,495
10 ops.
Buy Volume
n/a
4 ops.
Sell Volume
22Σ signal
Buys €17,495n/a Sells
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
Excel Therapeutics es una empresa farmacéutica y de atención médica que cotiza en el mercado XKRX. Se especializa en el desarrollo de terapias innovadoras.